Eviva Pharma Limited 31/03/2020 iXBRL

Eviva Pharma Limited 31/03/2020 iXBRL

EVIVA PHARMA LIMITED - Company Information

Print Friendly Version

31/03/2020 2020-03-31 false false false false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2019-04-01 Sage Accounts Production 19.0 - FRS102_2019 xbrli:pure xbrli:shares iso4217:GBP 06499225 2019-04-01 2020-03-31 06499225 2020-03-31 06499225 2019-03-31 06499225 bus:RegisteredOffice 2019-04-01 2020-03-31 06499225 bus:LeadAgentIfApplicable 2019-04-01 2020-03-31 06499225 bus:Director1 2019-04-01 2020-03-31 06499225 core:WithinOneYear 2020-03-31 06499225 core:WithinOneYear 2019-03-31 06499225 bus:Micro-entities 2019-04-01 2020-03-31 06499225 bus:AuditExemptWithAccountantsReport 2019-04-01 2020-03-31 06499225 bus:FullAccounts 2019-04-01 2020-03-31 06499225 bus:SmallCompaniesRegimeForAccounts 2019-04-01 2020-03-31 06499225 bus:PrivateLimitedCompanyLtd 2019-04-01 2020-03-31
Company registration number: 06499225
Eviva Pharma Limited
Unaudited filleted financial statements
31 March 2020
Eviva Pharma Limited
Contents
Directors and other information
Accountant's report
Statement of financial position and notes to the financial statements
Eviva Pharma Limited
Directors and other information
Director J M Rennie
Company number 06499225
Registered office Knoll House
Knoll Road
Camberley
Surrey
GU15 3SY
Accountant Accountancy Matters
Chartered Accountants
147 Ship Lane
Farnborough
Hants
GU14 8BJ
Eviva Pharma Limited
Chartered accountant's report to the director on the preparation of the
unaudited statutory financial statements of Eviva Pharma Limited
Year ended 31 March 2020
In order to assist you to fulfil your duties under the Companies Act 2006, I have prepared for your approval the financial statements of Eviva Pharma Limited for the year ended 31 March 2020 which comprise the statement of financial position and related notes from the company's accounting records and from information and explanations you have given me.
As a practising member of the Institute of Chartered Accountants in England and Wales (ICAEW), I am subject to its ethical and other professional requirements which are detailed at http://www.icaew.com /en/members/regulations-standards-and-guidance/.
This report is made solely to the director of Eviva Pharma Limited, as a body, in accordance with the terms of my engagement letter. My work has been undertaken solely to prepare for your approval the financial statements of Eviva Pharma Limited and state those matters that we have agreed to state to them, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, I do not accept or assume responsibility to anyone other than Eviva Pharma Limited and its director as a body for my work or for this report.
It is your duty to ensure that Eviva Pharma Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Eviva Pharma Limited. You consider that Eviva Pharma Limited is exempt from the statutory audit requirement for the year.
I have not been instructed to carry out an audit or a review of the financial statements of Eviva Pharma Limited. For this reason, I have not verified the accuracy or completeness of the accounting records or information and explanations you have given to me and I do not, therefore, express any opinion on the statutory financial statements.
Accountancy Matters
Chartered Accountants
147 Ship Lane
Farnborough
Hants
GU14 8BJ
12 July 2020
Eviva Pharma Limited
Statement of financial position
31 March 2020
2020 2019
£ £ £ £
Fixed assets 583,827 553,103
_______ _______
Current assets 113,538 117,109
Prepayments and accrued income 1,943 1,617
_______ _______
115,481 118,726
Creditors: amounts falling due within one year ( 72,784) ( 19,815)
_______ _______
Net current assets 42,697 98,911
_______ _______
Total assets less current liabilities 626,524 652,014
Provisions for liabilities - ( 2,103)
Accruals and deferred income ( 1,200) ( 2,850)
_______ _______
Net assets 625,324 647,061
_______ _______
Capital and reserves 625,324 647,061
_______ _______
Notes to the financial statements
Eviva Pharma Limited
Year ended 31 March 2020
1. Employee numbers
The average number of persons employed by the company during the year amounted to Nil (2019: Nil).
For the year ending 31 March 2020 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
- The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 12 July 2020 , and are signed on behalf of the board by:
J M Rennie
Director
Company registration number: 06499225
The company is a private company limited by shares, registered in England and Wales.